(Q39866037)

15 September 2017

Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

Gatti G

1

1 reference

15 September 2017

Flaherty J

2

1 reference

15 September 2017

Bubp J

3

1 reference

15 September 2017

White J

4

1 reference

15 September 2017

Borin M

5

1 reference

15 September 2017

Gambertoglio J

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

37

1 reference

15 September 2017

5

1 reference

15 September 2017

1137-1143

1 reference

Antibacterial activity and pharmacokinetics of clindamycin

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Role of clindamycin in the treatment of central nervous system toxoplasmosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Clindamycin in a murine model of toxoplasmic encephalitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Assessment of therapy for toxoplasma encephalitis. The TE Study Group

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

In vitro assessment of antimicrobial agents against Toxoplasma gondii

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

AIDS commentary. Toxoplasmic encephalitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

The absorption of antibiotics in adult patients with coeliac disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Folic acid absorption in patients infected with the human immunodeficiency virus

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Clindamycin dose-bioavailability relationships.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Clindamycin in cerebral toxoplasmosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Kinetics of D-xylose absorption in patients with human immunodeficiency virus enteropathy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187917

Enteropathy associated with the acquired immunodeficiency syndrome

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8517703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of toxoplasmic encephalitis with intravenous clindamycin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8517703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.5.1137

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

8517703

1 reference